GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aiobio Co Ltd (XKRX:447690) » Definitions » Change In Receivables

Aiobio Co (XKRX:447690) Change In Receivables : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Aiobio Co Change In Receivables?

Aiobio Co's change in receivables for the quarter that ended in . 20 was ₩0.00 Mil. It means Aiobio Co's Accounts Receivable stayed the same from . 20 to . 20 .

Aiobio Co's change in receivables for the fiscal year that ended in . 20 was ₩0.00 Mil. It means Aiobio Co's Accounts Receivable stayed the same from . 20 to . 20 .

Aiobio Co's Accounts Receivable for the quarter that ended in . 20 was ₩0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Aiobio Co's liquidation value for the six months ended in . 20 was ₩0.00 Mil.


Aiobio Co Change In Receivables Historical Data

The historical data trend for Aiobio Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aiobio Co Change In Receivables Chart

Aiobio Co Annual Data
Trend
Change In Receivables

Aiobio Co Semi-Annual Data
Change In Receivables

Aiobio Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aiobio Co  (XKRX:447690) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Aiobio Co's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of liquidation value, Aiobio Co's accounts receivable are only considered to be worth 75% of book value:

Aiobio Co's liquidation value for the quarter that ended in . 20 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aiobio Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Aiobio Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Aiobio Co (XKRX:447690) Business Description

Traded in Other Exchanges
N/A
Address
38, Teheran-ro 4-gil, 8th Floor, Gangnam-gu, Seoul, KOR, 06241
Aiobio Co Ltd manufactures products for dental checkup services. Its product includes Qraycam Pro; Qraypen C, W-Block; Qray SW; Qrayview C, Goggles; Qray m and Qscan plus.

Aiobio Co (XKRX:447690) Headlines

No Headlines